Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight inflows into CNOOC, Meituan, Xiaomi, alongside utility names.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight inflows into CNOOC, Meituan, Xiaomi, alongside utility names.


Hong Kong Connect Flows: Chinese Were Buying Utilities Towards End of 2021

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We note inflows into Tencent, Xiaomi, CNOOC, and Kuaishou before the Christmas holiday. </li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We note inflows into Tencent, Xiaomi, CNOOC, and Kuaishou before the Christmas holiday. 


Hong Kong Connect Flows: Chinese Buying Tencent, Xiaomi, CNOOC and Kuaishou Before Xmas

<ul>
<li>We analyze the weekly Hong Kong Connect flows with our data engine as of record day of December 17th.</li>
<li>The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.</li>
<li>We highlight inflows into Tencent, Meituan and Tsingtao, as well as outflows from Wuxi Biologics, Xiaomi, and Great Wall Motor.</li>
</ul>


We analyze the weekly Hong Kong Connect flows with our data engine as of record day of December 17th.
The top stocks by inflows and outflows were tabulated for all market, HSCEI, mid cap and s/mid cap groups.
We highlight inflows into Tencent, Meituan and Tsingtao, as well as outflows from Wuxi Biologics, Xiaomi, and Great Wall Motor.


Hong Kong Connect Flows: Chinese Buying Tsingtao Brewery

<ul>
<li>We analyze statistics on top repurchases over one week, one month, one quarter and one year periods ended on Dec 17 based on HKEx daily reports.</li>
<li>In the past 7 days, the top 3 companies that repurchased the most shares from the market were Wuxi Biologics (2269 HK), Ping An H&amp;T (1833 HK), Xiaomi (1810 HK).</li>
<li>In the past 30 days, the top 3 companies that repurchased the most shares from the market were Wuxi Biologics (2269 HK), Xiaomi (1810 HK), Cspc Pharmaceutical (1093 HK).</li>
</ul>


We analyze statistics on top repurchases over one week, one month, one quarter and one year periods ended on Dec 17 based on HKEx daily reports.
In the past 7 days, the top 3 companies that repurchased the most shares from the market were Wuxi Biologics (2269 HK), Ping An H&amp;T (1833 HK), Xiaomi (1810 HK).
In the past 30 days, the top 3 companies that repurchased the most shares from the market were Wuxi Biologics (2269 HK), Xiaomi (1810 HK), Cspc Pharmaceutical (1093 HK).


Hong Kong Buybacks: Wuxi Biologics Spent HKD700m in a Day

Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Pan-Asia Index Rebalances/ Events/ Delta One

Event-Driven

Hang Seng China Enterprises Index / Event-Driven

<ul>
<li>With the 2021 futures expiring in 2 weeks, the focus now shifts to the HSCEI dividend futures expiring in 2022 where we see a fair value of 240.76 DIPS.</li>
<li>The current market is trading very close to our fair value for 2022 but there are a lot of potential catalysts that could result in a big move lower.</li>
<li>There are fewer catalysts for the 2022 futures to move higher. The regulatory changes in China plus the HFCAA could lead to the 2023 futures trading cheaper to 2022.</li>
</ul>


With the 2021 futures expiring in 2 weeks, the focus now shifts to the HSCEI dividend futures expiring in 2022 where we see a fair value of 240.76 DIPS.
The current market is trading very close to our fair value for 2022 but there are a lot of potential catalysts that could result in a big move lower.
There are fewer catalysts for the 2022 futures to move higher. The regulatory changes in China plus the HFCAA could lead to the 2023 futures trading cheaper to 2022.


HSCEI Dividend Futures: 2022 Close to Fair; Sell 22/23 Steepener

China

Xiaomi Corporation manufactures communication equipment and parts. The Company produces and sells mobile phones, smart phone software,  set-top boxes, and related accessories. Xiaomi markets its products worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Xiaomi Corp (1810 HK)

Hong Kong Connect Flows: Chinese Were Buying Utilities Towards End of 2021

We highlight weekly Hong Kong Connect inflows into CNOOC, Meituan, Xiaomi, alongside utility names (Longyuan, China Resource Power, China Power...

Ke Yan, CFA, FRM

Hong Kong Connect Flows: Chinese Buying Tencent, Xiaomi, CNOOC and Kuaishou Before Xmas

We highlight Hong Kong Connect inflows into Tencent (700 HK), Xiaomi (1810 HK), Cnooc (883 HK) and Kuaishou (1024 HK), as well as outflows from...

Ke Yan, CFA, FRM

Hong Kong Connect Flows: Chinese Buying Tsingtao Brewery

We highlight Hong Kong Connect inflows into Tencent (700 HK), Meituan (3690 HK), Tsingtao Brewery (168 HK), and outflows from Wuxi Biologics (2269...

Ke Yan, CFA, FRM

Hong Kong Buybacks: Wuxi Biologics Spent HKD700m in a Day

We highlight the top 3 companies that repurchased the most shares in HK were Wuxi Biologics (2269 HK), Ping An Healthcare And Technology (1833 HK),...

Ke Yan, CFA, FRM

HSCEI Dividend Futures: 2022 Close to Fair; Sell 22/23 Steepener

The HSCEI 2022 dividend futures are trading close to fair but there are a lot more negative catalysts that will have a bigger impact than positive...

Brian Freitas

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)